Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Sites / Beth Israel Deaconess Medical Center / Wagner, Andrew

Wagner, Andrew (M.D.)

PI, Beth Israel Deaconess Medical Center, 617-667-2898

Contact Information

Email: mailto:awagner@bidmc.harvard.edu
Fax:
EDRN Associate Member

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
A Methylation Panel for Bladder Cancer 0 0
EDRN Pre-Validation of Metabolic Biomarkers of Prostate Cancer: Follow up EDRN Challenge 0 0
EDRN Pre-Validation of Multiplex Biomarker in Urine 2 0
Prostate Active Surveillance Study 2 0

Closed Protocols

Protocol Name Biomarkers Datasets
Biomarker Detection Using NAPPA Tumor Antigen Arrays: EDRN Supplement 28 0
EDRN Resource Network Exchange 0 0
Methylation & Proteomics-Based Detection of Bladder Cancer 0 0
PCA3 Validation Study and Urinary Reference Set 2 0
Prostate Rapid Pre-Validation Set 6 0
Prostate Reference Set Application: proPSA-Dan Chan-JHU (2008) 2 0
Prostate Upgrading Team Project 0 0
Standard Specimen Reference Set: Prostate 0 0

Publications

No publications found.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

330 Brookline Avenue, RABB 440
Beth Israel Deaconess Medical Center

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

32nd SC Meeting
Thank you to everyone who made the 32nd EDRN Steering Committee meeting a success. The next event is the 10th EDRN Scientific Workshop from March 6-8, 2018 in Bethesda, MD. More information about this Workshop will be sent soon. Click here to view the flyer.
EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.